Melissa Palmer, M.D.

Dr. Melissa Palmer currently serves as the CEO of Liver Consulting LLC, consulting exclusively to biotech and pharmaceutical companies on hepatology-related issues such as: innovative trial designs for all liver diseases including MASH and PSC, all aspects of liver disease drug development from pre-IND to NDA and launch, hepatic impairment studies, regulatory interactions including IND, NDA, and responding to regulatory feedback from the Agencies, liver adverse event signal evaluation during clinical trials, (drug-induced liver injury, formation of and chairing scientific and medical advisory boards, data-safety monitoring committees and Hepatology safety adjudication committees.